{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:02:47Z","timestamp":1793026967554,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.012","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T17:36:24Z","timestamp":1346348184000},"page":"6600-6607","source":"Crossref","is-referenced-by-count":72,"title":["Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel"],"prefix":"10.1016","volume":"30","author":[{"given":"S.","family":"Ben-Shimol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Glikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.08.012_bib0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1542\/pir.25-12-418","article-title":"Pneumococcal infections","volume":"25","author":"Durbin","year":"2004","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/00365548.2010.510532","article-title":"Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine","volume":"42","author":"Laitinen","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0030","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2893.2009.01176.x","article-title":"Hepatitis A disease following the implementation of universal vaccination: who is at risk?","volume":"17","author":"Mor","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0045","series-title":"The 49th annual meeting of the Infectious Diseases Society of America","article-title":"Streptococcus pneumoniae nasopharyngeal carriage among school children 6\u201310 years old from 2 ethnic populations, 12\u201318 months after introduction of the 7-valent pneumococcal conjugate vaccine into the national immunization program [Abstract 660]","author":"Greenberg","year":"2011"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0050","first-page":"137","article-title":"Community acquired pneumonia (CAP) in children younger than 5 years of age in southern Israel","volume":"149","author":"Ben-Shimol","year":"2010","journal-title":"Harefuah"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00006454-199305000-00006","article-title":"Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus","volume":"12","author":"Dagan","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/321874","article-title":"A decade (1989\u20131998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice","volume":"33","author":"Fraser","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0065","series-title":"Bailey and Scott's diagnostic microbiology. Streptococci, including enterococci and pneumococci and aerococcus","first-page":"333","year":"1990"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/INF.0b013e3181b78e6e","article-title":"Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel","volume":"29","author":"Porat","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0075","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1128\/IAI.00510-07","article-title":"Genetic basis for the new pneumococcal serotype, 6C","volume":"75","author":"Park","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0080","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case\u2013control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0085","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0090","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.vaccine.2009.04.057","article-title":"Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany","volume":"27","author":"Ruckinger","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0095","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0100","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0105","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00431-010-1214-7","article-title":"Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience","volume":"169","author":"Crisinel","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/INF.0b013e3181cffa2a","article-title":"Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada","volume":"29","author":"Deceuninck","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"Obaro","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.2009.975","article-title":"Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial","volume":"302","author":"van Gils","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0140","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/521831","article-title":"Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine","volume":"196","author":"Lipsitch","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0145","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings","volume":"28","author":"Cheung","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0150","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0155","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(00)02779-3","article-title":"Prevention of pneumococcal disease by vaccination: does serotype replacement matter","volume":"356","author":"Spratt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0165","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/590001","article-title":"Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine","volume":"47","author":"Lacapa","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0175","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/651680","article-title":"Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease","volume":"50","author":"Weatherholtz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998\u20132007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0190","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0195","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0200","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.vaccine.2006.09.011","article-title":"Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)","volume":"25","author":"Isaacman","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0205","series-title":"The 51st interscience conference on antimicrobial agents and chemotherapy","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old, US, 2010 [Abstract G1-538]","author":"Moore","year":"2011"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0210","series-title":"The 49th annual meeting of the Infectious Diseases Society of America","article-title":"Early trends for invasive pneumococcal infections in children following the introduction of the 13-valent pneumococcal conjugate vaccine","author":"Kaplan","year":"2011"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0215","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0220","series-title":"51st Interscience conference on antimicrobial agents and chemotherapy","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on nasopharyngeal flora in children with acute otitis media","author":"Cohen","year":"2011"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0225","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2012.08.012_bib0230","first-page":"102","article-title":"The dangerous synergism between influenza and Streptococcus pneumoniae and innovative perspectives of vaccine prevention","volume":"52","author":"Alicino","year":"2011","journal-title":"J Prev Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T23:14:11Z","timestamp":1643325251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12011917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":46,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X12011917"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}